Zacks.com featured highlights include Dana, Ingevity, Compania de Minas Buenaventura, Noble and Suzano
Werte in diesem Artikel
For Immediate ReleaseChicago, IL – February 10, 2025 – Stocks in this week’s article are — Dana Inc. DAN, Ingevity Corp. NGVT, Compania de Minas Buenaventura S.A.A. Inc. BVN, Noble Corp. NE and Suzano S.A. SUZ.Time to Buy These 5 Value Stocks with High Earnings YieldsMarkets are on edge as tariff concerns escalate and rate cuts remain elusive. With global trade tensions rattling supply chains and the Fed holding firm on rates, volatility is expected to continue. In times like these, value investing — seeking fundamentally strong stocks trading below their intrinsic worth — is one of the best strategies to identify solid opportunities amid the chaos.One interesting ratio that you can consider for ferreting out attractively valued stocks is earnings yield. Stocks like Dana Inc., Ingevity Corp., Compania de Minas Buenaventura S.A.A. Inc., Noble Corp. and Suzano S.A. boast impressive earnings yield to help you fetch handsome long-term rewards.Earnings Yield StrengthEarnings yield, expressed in percentage, is calculated as annual earnings per share (EPS) divided by market price. This metric measures the anticipated yield (or return) from earnings for each dollar invested in a stock today. While comparing stocks, if other factors are similar, the ones with higher earnings yield are considered undervalued, while those with lower earnings yield are seen as overpriced.While earnings yield is nothing but the reciprocal of the P/E ratio, it is a little more illuminating than the traditional P/E ratio as it also facilitates the comparison of stocks with fixed-income securities. Investors often compare the earnings yield of a stock to the prevailing interest rates, such as the current 10-year Treasury yield, to get a sense of the return on investment it offers compared to virtually risk-free returns.If the yield on a stock is lower than the 10-year Treasury yield, it would be considered overvalued relative to bonds. Conversely, if the yield on the stock is higher, it would be considered undervalued. In this situation, investing in the stock market would be a better option for a value investor.We have highlighted five of the 49 stocks that qualified the screening:Dana is a provider of power conveyance and energy-management solutions for vehicles and machinery in North America, Europe, South America and the Asia Pacific. The Zacks Consensus Estimate for DAN’s 2025 earnings implies year-over-year growth of 79%. Estimates for 2025 earnings per share have moved up by 20 cents over the past 30 days. Dana currently sports a Zacks Rank #1 and has a Value Score of A.Ingevity is a global producer of high-performance activated carbon materials and specialty chemicals. The Zacks Consensus Estimate for NGVT’s 2025 earnings implies year-over-year growth of 62%. Estimates for 2025 earnings per share have moved up by $1 over the past 30 days. Ingevity currently sports a Zacks Rank #1 and has a Value Score of B.Buenaventura engages in the exploration, development, construction and operation of mineral processing business. The Zacks Consensus Estimate for BVN’s 2025 earnings implies year-over-year growth of 30.5%. Estimates for 2025 earnings per share have moved up by 3 cents over the past 30 days. Buenaventura currently sports a Zacks Rank #1 and has a Value Score of B.Noble is an offshore drilling contractor specializing in ultra-deepwater and high-specification jackup drilling services for the oil and gas industry. The Zacks Consensus Estimate for NE’s 2025 earnings implies year-over-year growth of 22%. Estimates for 2025 earnings per share have moved up by 8 cents over the past 30 days. Noble currently sports a Zacks Rank #1 and has a Value Score of A.Suzano is one of the largest vertically integrated producers of eucalyptus pulp and paper. The Zacks Consensus Estimate for SUZ’s 2025 earnings implies year-over-year growth of 395%. Estimates for 2025 earnings per share have moved up by 21 cents over the past 30 days. Suzano currently sports a Zacks Rank #1 and has a Value Score of A.You can get the rest of the stocks on this list by signing up now for a 2-week free trial to the Research Wizard stock picking and backtesting software. You can also create your own strategies and test them first before making investments.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial to the Research Wizard today.For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2411809/time-to-buy-these-5-value-stocks-with-high-earnings-yield?art_rec=quote-stock_overview-zacks_news-ID01-txt-2411809Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performance for information about the performance numbers displayed in this press release.Just Released: Zacks Top 10 Stocks for 2025Hurry – you can still get in early on our 10 top tickers for 2025. Handpicked by Zacks Director of Research Sheraz Mian, this portfolio has been stunningly and consistently successful. From inception in 2012 through November, 2024, the Zacks Top 10 Stocks gained +2,112.6%, more than QUADRUPLING the S&P 500’s +475.6%. Sheraz has combed through 4,400 companies covered by the Zacks Rank and handpicked the best 10 to buy and hold in 2025. You can still be among the first to see these just-released stocks with enormous potential. See New Top 10 Stocks >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Noble Corporation PLC (NE): Free Stock Analysis Report Dana Incorporated (DAN): Free Stock Analysis Report Buenaventura Mining Company Inc. (BVN): Free Stock Analysis Report Ingevity Corporation (NGVT): Free Stock Analysis Report Suzano S.A. Sponsored ADR (SUZ): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Quelle: Zacks
Nachrichten zu Ingevity Corp When Issued
Analysen zu Ingevity Corp When Issued
Datum | Rating | Analyst | |
---|---|---|---|
18.07.2019 | Ingevity Outperform | BMO Capital Markets | |
11.12.2018 | Ingevity Hold | Stifel, Nicolaus & Co., Inc. | |
10.06.2016 | Ingevity Buy | BB&T Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
18.07.2019 | Ingevity Outperform | BMO Capital Markets | |
11.12.2018 | Ingevity Hold | Stifel, Nicolaus & Co., Inc. | |
10.06.2016 | Ingevity Buy | BB&T Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Ingevity Corp When Issued nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen